Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 33,941 | 0 | 21,192 | 0 |
| Operating Income | -33,941 | N/A | -21,192 | N/A |
| Other Income | -995 | 0 | 4,618 | 0 |
| Pre-tax Income | -34,936 | 0 | -16,574 | 0 |
| Income Tax | 9 | N/A | 131 | N/A |
| Net Income Continuous | -34,945 | N/A | -16,705 | N/A |
| Net Income | $-34,945 | $N/A | $-16,705 | $N/A |
| EPS Basic Total Ops | -14.63 | N/A | -27.61 | N/A |
| EPS Basic Continuous Ops | -14.63 | N/A | -27.67 | N/A |
| EPS Diluted Total Ops | -14.63 | N/A | -27.61 | N/A |
| EPS Diluted Continuous Ops | -14.63 | N/A | -27.67 | N/A |
| EBITDA(a) | $-33,368 | $N/A | $-20,697 | $N/A |